Vita Life Sciences Ltd
ASX:VLS

Watchlist Manager
Vita Life Sciences Ltd Logo
Vita Life Sciences Ltd
ASX:VLS
Watchlist
Price: 2.64 AUD -5.71%
Market Cap: 144.2m AUD

Balance Sheet

Balance Sheet Decomposition
Vita Life Sciences Ltd

Balance Sheet
Vita Life Sciences Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
1
2
1
1
1
2
0
1
1
0
2
4
6
7
8
8
6
11
8
10
10
12
5
7
Cash
1
2
1
1
1
2
0
1
1
0
2
4
6
7
8
8
6
0
8
10
10
12
5
7
Cash Equivalents
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
0
0
0
0
0
0
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
1
1
3
2
2
2
4
0
2
4
6
4
19
21
Total Receivables
42
4
2
3
4
5
2
2
3
8
3
4
5
0
0
6
7
7
8
7
7
9
11
12
Accounts Receivables
38
3
2
3
3
1
1
2
2
2
3
3
4
0
0
5
6
7
7
6
7
9
11
12
Other Receivables
3
1
0
0
1
4
1
0
1
6
1
1
1
0
0
1
1
0
1
0
0
0
1
0
Inventory
7
7
6
4
3
2
2
3
3
3
4
6
6
0
0
5
5
6
7
7
11
15
11
17
Other Current Assets
0
0
1
1
1
4
0
0
0
0
0
0
1
0
0
1
1
1
1
1
1
1
1
2
Total Current Assets
49
13
10
10
8
13
5
6
7
12
11
16
20
0
0
22
22
25
26
29
35
41
48
59
PP&E Net
3
3
2
2
1
0
0
0
0
0
0
0
0
0
0
9
9
9
9
8
8
8
9
10
PP&E Gross
3
3
2
2
1
0
0
0
0
0
0
0
0
0
0
9
9
0
9
8
8
8
9
10
Accumulated Depreciation
2
2
2
2
2
1
1
2
2
2
2
2
2
2
2
1
2
0
3
3
3
3
3
3
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
11
8
8
7
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
1
1
2
2
1
1
0
1
1
1
1
0
0
0
0
0
0
Other Long-Term Assets
2
5
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
2
2
2
2
2
3
Other Assets
11
8
8
7
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
66
N/A
29
-56%
20
-32%
19
-3%
16
-16%
13
-19%
7
-48%
9
+28%
9
+2%
15
+65%
13
-8%
17
+26%
22
+31%
0
N/A
0
N/A
32
N/A
33
+2%
36
+8%
37
+2%
39
+7%
45
+16%
52
+14%
60
+15%
72
+20%
Liabilities
Accounts Payable
12
8
9
8
7
6
3
3
3
4
4
5
4
2
3
4
4
5
5
6
8
9
10
11
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
1
0
0
0
0
0
0
Short-Term Debt
2
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
2
0
1
3
8
1
1
1
2
0
0
0
0
0
0
0
0
1
1
0
0
0
0
Other Current Liabilities
10
2
1
1
1
0
0
0
0
0
1
1
2
0
0
3
1
5
6
6
7
6
6
8
Total Current Liabilities
25
13
12
12
11
15
4
5
5
6
4
5
6
2
4
7
6
11
12
13
14
15
16
19
Long-Term Debt
1
6
17
17
18
0
0
0
0
0
0
0
0
0
0
2
2
2
2
1
0
0
0
0
Deferred Income Tax
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Liabilities
26
N/A
20
-24%
29
+46%
29
+1%
30
+2%
15
-49%
4
-75%
5
+41%
5
0%
7
+27%
5
-29%
6
+14%
6
+5%
0
N/A
0
N/A
9
N/A
8
-11%
13
+63%
14
+4%
14
+3%
15
+1%
15
+5%
16
+8%
20
+19%
Equity
Common Stock
38
38
38
38
38
39
44
45
46
46
46
46
46
0
0
45
44
44
42
42
42
42
43
45
Retained Earnings
2
29
47
48
52
40
40
40
41
36
35
33
29
0
0
20
18
22
20
16
11
6
1
5
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
Other Equity
0
0
0
0
0
1
1
1
2
2
2
2
1
0
0
2
1
0
0
1
1
0
1
2
Total Equity
40
N/A
9
-77%
9
N/A
10
-9%
14
-35%
2
+84%
3
N/A
3
+12%
3
+6%
8
+124%
8
+11%
11
+33%
16
+44%
0
N/A
0
N/A
23
N/A
25
+7%
22
-10%
23
+1%
25
+9%
31
+24%
37
+19%
43
+19%
52
+21%
Total Liabilities & Equity
66
N/A
29
-56%
20
-32%
19
-3%
16
-16%
13
-19%
7
-48%
9
+28%
9
+2%
15
+65%
13
-8%
17
+26%
22
+31%
0
N/A
0
N/A
32
N/A
33
+2%
36
+8%
37
+2%
39
+7%
45
+16%
52
+14%
60
+15%
72
+20%
Shares Outstanding
Common Shares Outstanding
13
13
13
13
12
13
47
49
54
54
58
56
56
0
0
56
57
55
56
54
55
57
56
57